Double-blind study to confirm the effect of lactic acid bacteria N1487-7 on improving liver function -Placebo-controlled, double-blind, randomized, parallel-group comparative study- - Double-blind study to confirm the effect of lactic acid bacteria N1487-7 on improving liver function -Placebo-controlled, double-blind, randomized, parallel-group comparative study

Miura Clinic, Medical Corporation Kanonkai0 个研究点目标入组 100 人开始时间: 2023年8月20日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Subjests with heart, liver, and kidney diseases (including complications of other deseases) (2) Subjests with a history of cardiovascular disease (3) Subjests with diabetes (4) Subjests with diseases currently being treated (5) Subjests who are allergic to food and drugs (6) Subjests with anemia symptoms (7) Female subjects wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating gemale subjects (8) Subjests who go to the hospital for some illness or are treated with drugs and Chinese medicine (temporary administration is possible) (9) Subjests who play intense sports and subjects who are on a diet (10) Subjests with extremely irregular eating habits (11) Subjests who may change their lifestyle habits (various daily habits such as diet, exercise, smoking, drinking, and sleeping) during the intake period (12) Subjests who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (13) Subjests who drink more than 60g of avarage daily pure alcohol (14) Subjests who smoke an average of 21 or more cigarettes a day (15) Subjests who are participating in or will participate in other clinica trials at the start of this study (16) Other subjects judged by the investigator or the investigator to be inappropriate for the examination

发起方

Miura Clinic, Medical Corporation Kanonkai